LMTK3 as prognostic marker for ovarian cancer and TTX335o, award-winning drug candidate with tumor-killing activity, presented as game-changing treatment for women
Nova Biomedical is pleased to announce the launch of BioProfile FAST CDV, a high-throughput, fully automated viable cell density and viability analyzer capable of producing results in under 70 seconds with just 100μL of sample volume.
Facility owner and Director of Player Development, Mike Freire, shares his knowledge nationwide in a new collaborative podcast designed to use experience and scientific evidence to highlight the strategies that make his players successful.